Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides
- PMID: 9063885
- DOI: 10.1021/bi9621472
Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides
Abstract
Glycoproteins, such as immunoglobulin G (IgG), consist of an ensemble of glycosylated variants, or glycoforms, which have different oligosaccharides attached to a common peptide. Alterations in the normal glycoform populations of IgG are associated with certain disease states, notably rheumatoid arthritis and its remission during pregnancy. In this paper, we show that two sets of IgG Fc glycoforms have quite different physical properties. The first set has 1,6 arm terminal galactose residues which interact with the protein, resulting in glycan binding to the protein surface, in agreement with the crystal structure. In contrast, the second set of glycoforms which lack galactose does not bind to the protein surface. Recently developed HPLC techniques combined with enzymatic digestion and mass spectrometry have been used to assign the glycan structures on IgG, Fab, and Fc. Comparison of Fab with Fc shows that glycosylation is site-specific. Two major glycan structures are present on Fab (fucosylated digalacto-bianntenary with and without bisect) and three on Fc (fucosylated agalacto-, 1,6 arm monogalacto-, and digalacto-bianntenary). In comparison to Fab, Fc glycans contain (i) lower levels of bisecting GlcNAc, (ii) lower levels of galactose, (iii) higher than expected levels of 1,6 arm galactose relative to 1,3 arm, and (iv) no 1,6 arm sialylation. We interpret these differences to indicate a role for both the protein quaternary structure and specific protein-glycan interactions in determining the glycoform populations. NMR relaxation measurements have been used to probe the mobility of the glycans in the Fc. By comparing two samples with different glycoform populations, we conclude that this mobility is dependent on the primary sequence of the glycan. Glycans carrying a galactose residue on the 1,6 arm have relaxation properties very similar to those of the peptide backbone and thus do not have independent motion. Glycans lacking galactose have relaxation rates 30 times slower than that of the peptide and thus a higher degree of mobility. These agalactosyl glycans do not interact with the protein, resulting in exposure of previously covered regions of the peptide surface and making the glycan more accessible. This implies that at the early stages of glycan processing the Fc glycans are mobile and only partially protected by the protein quaternary structure. Immobilization of the glycans occurs as a consequence of addition of galactose to the 1,6 arm and results in increased protection.
Similar articles
-
Glycobiology: 'the function of sugar in the IgG molecule'.J Anat. 1995 Oct;187 ( Pt 2)(Pt 2):279-92. J Anat. 1995. PMID: 7591992 Free PMC article.
-
Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.J Immunol Methods. 2007 Sep 30;326(1-2):116-26. doi: 10.1016/j.jim.2007.07.014. Epub 2007 Aug 8. J Immunol Methods. 2007. PMID: 17714731
-
Site-specific N-glycosylation of chicken serum IgG.Glycobiology. 2004 Mar;14(3):275-92. doi: 10.1093/glycob/cwh031. Epub 2003 Dec 23. Glycobiology. 2004. PMID: 14693911
-
Terminal sugars of Fc glycans influence antibody effector functions of IgGs.Curr Opin Immunol. 2008 Aug;20(4):471-8. doi: 10.1016/j.coi.2008.06.007. Epub 2008 Jul 17. Curr Opin Immunol. 2008. PMID: 18606225 Review.
-
Methods in enzymology: O-glycosylation of proteins.Methods Enzymol. 2005;405:139-71. doi: 10.1016/S0076-6879(05)05007-X. Methods Enzymol. 2005. PMID: 16413314 Review.
Cited by
-
General mechanism for modulating immunoglobulin effector function.Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72. doi: 10.1073/pnas.1307864110. Epub 2013 May 22. Proc Natl Acad Sci U S A. 2013. PMID: 23697368 Free PMC article.
-
Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides.Glycoconj J. 2013 Feb;30(2):137-46. doi: 10.1007/s10719-012-9443-9. Epub 2012 Aug 26. Glycoconj J. 2013. PMID: 22922975 Review.
-
The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.Semin Immunopathol. 2012 May;34(3):443-53. doi: 10.1007/s00281-012-0308-x. Epub 2012 Mar 22. Semin Immunopathol. 2012. PMID: 22437760 Review.
-
Hypogalactosylation of serum IgG in patients with coeliac disease.Clin Exp Immunol. 2003 Sep;133(3):422-9. doi: 10.1046/j.1365-2249.2003.02220.x. Clin Exp Immunol. 2003. PMID: 12930370 Free PMC article.
-
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.Sci Rep. 2020 Jan 30;10(1):1464. doi: 10.1038/s41598-019-57393-9. Sci Rep. 2020. PMID: 32001734 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources